Mangoceuticals advances in H1N1 and H5N1 studies
DALLAS - Mangoceuticals, Inc. (NASDAQ: MGRX), a telemedicine company focused on men's wellness products with a market capitalization of $8.12 million, has announced progress in its H1N1 efficacy study ...
Investor's Business Daily on MSN17m
MicroStrategy Rebrands, Posts Major Loss, Pauses Bitcoin Buying Spree
MicroStrategy rebrands, misses estimates as losses widen. The software company went on a 12-week bitcoin buying spree ahead of results.